XML 73 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Other Ownership Interests
The following table summarizes net income attributable to Sempra and transfers (to) from NCI, which shows the effects of changes in Sempra’s ownership interest in its subsidiaries on Sempra’s shareholders’ equity.
NET INCOME ATTRIBUTABLE TO SEMPRA AND TRANSFERS (TO) FROM NCI
(Dollars in millions)
 Three months ended
June 30, 2023		Six months ended
June 30, 2023
Sempra: 
Net income attributable to Sempra$615 $1,595 
Transfers (to) from NCI:
Increase in shareholders’ equity for sale of NCI— 18 
Net transfers (to) from NCI— 18 
Change from net income attributable to Sempra and transfers (to) from NCI$615 $1,613 
Schedule of Earnings Per Share, Basic and Diluted
EARNINGS PER COMMON SHARE COMPUTATIONS
(Dollars in millions, except per share amounts; shares in thousands)
 Three months ended June 30,Six months ended June 30,
 2024202320242023
Sempra:
Numerator:    
Earnings attributable to common shares$713 $603 $1,514 $1,572 
Denominator:    
Weighted-average common shares outstanding for basic EPS(1)
633,450 630,014 633,135 629,926 
Dilutive effect of common shares sold forward1,139 — 906 — 
Dilutive effect of stock options and RSUs(2)
1,690 2,107 1,776 2,259 
Weighted-average common shares outstanding for diluted EPS636,279 632,121 635,817 632,185 
EPS:
Basic$1.13 $0.96 $2.39 $2.50 
Diluted$1.12 $0.95 $2.38 $2.49 
(1)    Includes 610 and 710 fully vested RSUs held in our Deferred Compensation Plan for the three months ended June 30, 2024 and 2023, respectively, and 617 and 715 of such RSUs for the six months ended June 30, 2024 and 2023, respectively. These fully vested RSUs are included in weighted-average common shares outstanding for basic EPS because there are no conditions under which the corresponding shares will not be issued.
(2)    Due to market fluctuations of both Sempra common stock and the comparative indices used to determine the vesting percentage of our total shareholder return performance-based RSUs, which we discuss in Note 10 of the Notes to Consolidated Financial Statements in the Annual Report, dilutive RSUs may vary widely from period-to-period.